These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 2073870

  • 1. Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy.
    Tajiri Y, Inoguchi T, Umeda F, Nawata H.
    Diabetes Res Clin Pract; 1990; 10(3):231-9. PubMed ID: 2073870
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandins and diabetic nephropathy.
    Umeda F, Kuroki T, Nawata H.
    J Diabetes Complications; 1995; 9(4):334-6. PubMed ID: 8573760
    [Abstract] [Full Text] [Related]

  • 3. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
    Tajiri Y, Umeda F, Inoguchi T, Kunisaki M, Nawata H, Ninomiya H, Asano T.
    Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
    [Abstract] [Full Text] [Related]

  • 4. Effects of thromboxane synthetase inhibitor (OKY-046) on urinary prostaglandin excretion and renal function in streptozotocin-induced diabetic rat.
    Tajiri Y, Umeda F, Inoguchi T, Nawata H.
    J Diabetes Complications; 1994 Mar; 8(2):126-32. PubMed ID: 8061349
    [Abstract] [Full Text] [Related]

  • 5. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T, Kameda H, Ichikawa Y, Tojo T, Homma M.
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [Abstract] [Full Text] [Related]

  • 6. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O, Nagatsuka K, Nakabayashi S, Isaka Y, Yoneda S, Kimura K, Abe H.
    Stroke; 1985 Oct; 16(2):241-4. PubMed ID: 3883580
    [Abstract] [Full Text] [Related]

  • 7. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Yoshida T, Ichikawa Y, Tojo T, Homma M.
    Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
    [Abstract] [Full Text] [Related]

  • 8. Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats.
    Okumura M, Imanishi M, Okamura M, Hosoi M, Okada N, Konishi Y, Morikawa T, Miura K, Nakatani T, Fujii S.
    Life Sci; 2003 May 02; 72(24):2695-705. PubMed ID: 12679187
    [Abstract] [Full Text] [Related]

  • 9. Effects of cilostazol, a phosphodiesterase inhibitor, on urinary excretion of albumin and prostaglandins in non-insulin-dependent diabetic patients.
    Watanabe J, Sako Y, Umeda F, Nawata H.
    Diabetes Res Clin Pract; 1993 May 02; 22(1):53-9. PubMed ID: 8137717
    [Abstract] [Full Text] [Related]

  • 10. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A.
    J Clin Invest; 1985 Sep 02; 76(3):1011-8. PubMed ID: 3900132
    [Abstract] [Full Text] [Related]

  • 11. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA, Andres GA, Dunn MJ.
    J Clin Invest; 1983 Oct 02; 72(4):1439-48. PubMed ID: 6685136
    [Abstract] [Full Text] [Related]

  • 12. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov 02; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 13. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
    Hora K, Oguchi H, Furukawa T, Hora K, Tokunaga S.
    Nephron; 1990 Nov 02; 56(3):297-305. PubMed ID: 2077412
    [Abstract] [Full Text] [Related]

  • 14. Renal production of thromboxane and prostaglandins in a rat model of type 2 diabetes.
    Okumura M, Imanishi M, Yamashita T, Yamamura Y, Kim S, Iwao H, Tanaka S, Fujii S.
    Life Sci; 2000 Nov 02; 66(5):371-7. PubMed ID: 10670825
    [Abstract] [Full Text] [Related]

  • 15. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K, Ikata T, Tounai T.
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan 02; 64(1):82-8. PubMed ID: 2319197
    [Abstract] [Full Text] [Related]

  • 16. Rabbit nephrotoxic nephritis: effect of a thromboxane synthetase inhibitor on evolution and prostaglandin excretion.
    Shinkai Y, Cameron JS.
    Nephron; 1987 Jan 02; 47(3):211-9. PubMed ID: 3317092
    [Abstract] [Full Text] [Related]

  • 17. Renal hemodynamics and urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in newly diagnosed type I diabetic patients.
    Gambardella S, Andreani D, Cancelli A, Di Mario U, Cardamone I, Stirati G, Cinotti GA, Pugliese F.
    Diabetes; 1988 Aug 02; 37(8):1044-8. PubMed ID: 3391343
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets.
    Uotila P, Matintalo M.
    Prostaglandins Leukot Med; 1984 Apr 02; 14(1):41-6. PubMed ID: 6427791
    [Abstract] [Full Text] [Related]

  • 19. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
    Coffman TM, Ruiz P, Sanfilippo F, Klotman PE.
    Kidney Int; 1989 Jan 02; 35(1):24-30. PubMed ID: 2651752
    [Abstract] [Full Text] [Related]

  • 20. Effect of acute thromboxane A2 inhibition on the renal hemodynamics in a spontaneously non-insulin-dependent diabetic rat, Otsuka Long-Evans Tokushima Fatty rat.
    Uriu K, Kaizu K, Qie YL, Kai K, Eto S.
    J Diabetes Complications; 1999 Jan 02; 13(4):182-6. PubMed ID: 10616856
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.